ASTA Comments to FDA on Voluntary Sesame Labeling Guidance
ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
ASTA Letter to Chairman Dingell on Proposed Food Safety Legislation
ASTA sent a letter to to Chairman Dingell of the U.S. House of Representatives expressing support for ensuring the safety of the nation's food supply through a well-funded FDA while opposing certain provisions, including those of proposed taxes on food facilities and importers, facility certification requirements for all food imports, and new regulatory requirements such as labeling mandates and civil penalties.
ASTA Comments on FDA's Post-Market Assessment of Chemicals in Food
In January 2025, ASTA submitted comments to the U.S. Food and Drug Administration (FDA) on its discussion paper on the development of an enhanced systematic process for the post-market assessment of chemicals in food. ASTA's comment note that environmental contaminants are unique and should be addressed using a separate or modified approach to that used for intentionally added chemicals. The comments also call for the development of additional guidance to assist industry with setting appropriate thresholds for contaminants.
